Die Information für Ärzte und Apotheker
Neutral, unabhängig und anzeigenfrei
arznei-telegramm®
previous issue next issue
This is a translation of the table of contents. One article is translated and freely available.

NEW ON THE MARKET
Rimegepant (VYDURA) for the treatment of acute migraine
Bevacizumab gamma (LYTENAVA) for wet macular degeneration

a-t READERS QUESTIONS AND COMMENTS
Coenzym Q10 in statin-treated patients – what's new?

IN BRIEF
Respiratory syncytial virus vaccination with the mRNA vaccine mRESVIA?
Atrial fibrillation: when to start with anticoagulation after stroke?
New flu vaccines for the 2024-2025 season
Structured exercise after adjuvant chemotherapy for colon cancer
Where the money goes: drugs with the highest turnover 2024-2025

SIDE EFFECTS
Caution: hypercalcaemia due to antacids in pregnancy
Lasting damage caused by lash extensions, eyeliner tattoos and other procedures  free article 

e a-t ON THE INTERNET
Bevacizumab gamma (LYTENAVA) for wet macular degeneration (long version)
Atrial fibrillation: when to start with anticoagulation after stroke? (long version)
© 2025 arznei-telegramm